Upstream Processing: A New Approach For Scalability and Transfer | CPhI North America

CPhI North America is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

 

View, browse and sort the ever-growing list of sessions by pass type, track, and format. With this Session Scheduler, you can build your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.

Upstream Processing: A New Approach For Scalability and Transfer

Guillaume Plane (Global Development and Marketing Manager, End-To-End BioReliance® Solutions, MilliporeSignma, MilliporeSigma)

Location: E353a

Date: Wednesday, May 1

Time: 9:45am - 10:30am

Track: Bio-Processing Symposium

Vault Recording: TBD

From DNA to market, a fair balance between fast and efficient is key, for the development of a new biological drug. New trends generate new constraints: Cost pressure leads to a need for higher titers, uncertainty leads to a need for risk mitigation. But experience shows that time to market can be dramatically compromised by inability to efficiently upscale or transfer an upstream process, leading to a huge waste of time during clinical development. This presentation will focus on a new approach, based on data mining, allowing an efficient and time-consistent process tech transfer, providing an advantage to drug makers for risk and yield management.

The main audience would be CXO people from biotech companies, or CMC consultants, or Process development scientists.